Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Torrent Pharmaceuticals Ltd ( (IN:TORNTPHARM) ) is now available.
Torrent Pharmaceuticals’ equity shareholders have approved, by the requisite majority, a Scheme of Amalgamation under which J. B. Chemicals & Pharmaceuticals Ltd will be merged into Torrent Pharmaceuticals along with their respective shareholders. The vote, conducted via remote e-voting and at an NCLT-convened meeting held through video conferencing on April 28, 2026, clears a key shareholder-level hurdle for the consolidation, which is expected to strengthen Torrent’s scale and positioning in the Indian pharmaceutical market, subject to remaining regulatory and court approvals.
More about Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is an Indian pharmaceutical company engaged in the development, manufacture and marketing of branded and generic medicines. The company focuses on prescription drugs across multiple therapeutic areas and is listed on both BSE and NSE, giving it access to a broad base of domestic and international investors.
Average Trading Volume: 13,914
Technical Sentiment Signal: Buy
Current Market Cap: 1392.9B INR
For detailed information about TORNTPHARM stock, go to TipRanks’ Stock Analysis page.